MAPT and Alzheimer disease: Both tauopathies share a series of culprit tau phosphorylation sites (Katsumoto et al., 2019) and TBI (but not necessarily rmTBI) is a risk factor for AD (Nemetz et al., 1999; Schaffert et al., 2018).